GB0602632D0 - Preparation Of A Solid Dosage From Comprising Tacrolimus And/Or Sirolimus - Google Patents

Preparation Of A Solid Dosage From Comprising Tacrolimus And/Or Sirolimus

Info

Publication number
GB0602632D0
GB0602632D0 GB0602632A GB0602632A GB0602632D0 GB 0602632 D0 GB0602632 D0 GB 0602632D0 GB 0602632 A GB0602632 A GB 0602632A GB 0602632 A GB0602632 A GB 0602632A GB 0602632 D0 GB0602632 D0 GB 0602632D0
Authority
GB
United Kingdom
Prior art keywords
sirolimus
tacrolimus
preparation
solid dosage
dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0602632A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fidelta doo
Original Assignee
Pliva Istrazivacki Institut doo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Istrazivacki Institut doo filed Critical Pliva Istrazivacki Institut doo
Priority to GB0602632A priority Critical patent/GB0602632D0/en
Publication of GB0602632D0 publication Critical patent/GB0602632D0/en
Priority to PCT/GB2007/000422 priority patent/WO2007091059A1/en
Ceased legal-status Critical Current

Links

GB0602632A 2006-02-08 2006-02-08 Preparation Of A Solid Dosage From Comprising Tacrolimus And/Or Sirolimus Ceased GB0602632D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB0602632A GB0602632D0 (en) 2006-02-08 2006-02-08 Preparation Of A Solid Dosage From Comprising Tacrolimus And/Or Sirolimus
PCT/GB2007/000422 WO2007091059A1 (en) 2006-02-08 2007-02-06 Preparation and composition of a solid dosage form containing tacrolimus and/or sirolimus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0602632A GB0602632D0 (en) 2006-02-08 2006-02-08 Preparation Of A Solid Dosage From Comprising Tacrolimus And/Or Sirolimus

Publications (1)

Publication Number Publication Date
GB0602632D0 true GB0602632D0 (en) 2006-03-22

Family

ID=36119804

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0602632A Ceased GB0602632D0 (en) 2006-02-08 2006-02-08 Preparation Of A Solid Dosage From Comprising Tacrolimus And/Or Sirolimus

Country Status (2)

Country Link
GB (1) GB0602632D0 (en)
WO (1) WO2007091059A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013022201A1 (en) * 2011-08-11 2013-02-14 Dong-A Pharm. Co., Ltd. Process of preparing a stabilized and solubilized formulation of sirolimus derivatives
HUP1400075A2 (en) 2014-02-14 2015-08-28 Druggability Technologies Ip Holdco Jersey Ltd Complexes of sirolimus and its derivatives, process for the preparation thereof and pharmaceutical composition containing them

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8608080D0 (en) * 1986-04-02 1986-05-08 Fujisawa Pharmaceutical Co Solid dispersion composition
ZA9710927B (en) * 1996-12-06 1998-06-15 Fujisawa Pharmaceutical Co Pharmaceutical composition.
CN1133424C (en) * 1997-06-13 2004-01-07 惠氏公司 Rapamycin formulations for oral administration

Also Published As

Publication number Publication date
WO2007091059A1 (en) 2007-08-16

Similar Documents

Publication Publication Date Title
EP2101745A4 (en) Delivery of drugs
HK1193567A1 (en) Abuse resistant drug formulation
PL2001466T3 (en) Low-dose rapamycin for the treatment of vascular permeability-related diseases
TWI367212B (en) Dosage forms of palonosetron hydrochloride having improved stability and bioavailability
EP2081550A4 (en) Coating capsules with active pharmaceutical ingredients
PL2384754T3 (en) Pharmaceutical dosage forms
IL201008A0 (en) Modified release dosage forms of tacrolimus
IL194751A0 (en) Drugs and uses
IL197877A (en) Uses of aminomethyl-4-imidazole derivatives for the preparation of medicaments and medicaments comprising them
EP2067475A4 (en) Tacrolimus sustained-release preparation
GB2443336B (en) Spiruchostatin analogues and their medicinal use
IL199477A (en) Pharmaceutical dosage forms comtaining colesevelam and/or colesevelam hydrochloride and their use
HK1130049A1 (en) Tricyclic compound and pharmaceutical use thereof
IL197966A0 (en) Use of modified cyclosporin
EP2098513A4 (en) Tricyclic compound and pharmaceutical use thereof
ZA200710814B (en) A game of chance
EP2005964A4 (en) The medicament for treating hyperphospheremia and preparation thereof
GB0602632D0 (en) Preparation Of A Solid Dosage From Comprising Tacrolimus And/Or Sirolimus
IL195726A0 (en) Pharmaceutical compositions comprising a combination of piperidinoalkanol and decongestant
HU0600097D0 (en) Pharmaceutical composition comprising tacrolimus
GB2444393B (en) Detection and suppression of muscle tremors
GB0610207D0 (en) New forms of active pharmaceutical ingredient
HU0600502D0 (en) Active ingredient against candida

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)